You have 9 free searches left this month | for more free features.

np137

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • NP137
  • +4 more
  • (no location specified)
Sep 23, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • NP137
  • +2 more
  • (no location specified)
Sep 23, 2022

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • NP137
  • +2 more
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Lyon (NP137, anti-PD-1/PD-L1)

Recruiting
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2022

Endometrial Carcinoma, Cervix Carcinoma Trial in France (NP137, Pembrolizumab, Paclitaxel)

Recruiting
  • Endometrial Carcinoma
  • Cervix Carcinoma
  • NP137
  • +3 more
  • Bordeaux, France
  • +11 more
Jun 7, 2022